And most importantly, the background estimate of the activation-induced-cytidine-deaminase signature is already accounted for in the MutSigCVsyn analysis by integrating mutational context, as well as other candidate hypermutations in lymphomas, meaning they are statistically excluded from our candidate list. This evidence concerns the gene CDA and lymphoma.